Netherlands
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
17.37%
|
Dec. 31, 2023 | USD 44.64 | 0.29% |
|
Netherlands |
|
2 |
2.11%
|
Dec. 31, 2023 | USD 36.37 | -0.03% |
|
Netherlands |
|
3 |
-0.67%
|
Dec. 31, 2023 | USD 127.21 | -1.46% |
|
Netherlands |
|
4 |
-2.56%
|
Dec. 31, 2023 | USD 27.61 | 1.08% |
|
Netherlands |
|
5 |
-4.30%
|
Dec. 31, 2023 | USD 8.76 | -0.46% |
|
Netherlands |
|
6 |
-24.06%
|
Dec. 31, 2023 | USD 662.53 | -0.67% |
|
Netherlands |
|
7 |
-352.56%
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
8 |
-431.67%
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
9 |
-620.09%
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
10 |
-1,386.36%
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
11 |
-1,947.09%
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
The Healthcare company in Netherlands with the highest Net Income Margin is Qiagen N.V. (NYSE: QGEN) at 17.37%.
The Healthcare company in Netherlands with the lowest Net Income Margin is uniQure N.V. (NasdaqGS: QURE) at -1,947.09%.
The top 10 Healthcare companies in Netherlands by Net Income Margin are Qiagen N.V., Koninklijke Ahold Delhaize N.V., Redcare Pharmacy NV, Koninklijke Philips N.V., Pharming Group N.V., argenx SE, Merus N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V. and NewAmsterdam Pharma Company N.V..
The bottom 10 Healthcare companies in Netherlands by Net Income Margin are uniQure N.V., NewAmsterdam Pharma Company N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., Merus N.V., argenx SE, Pharming Group N.V., Koninklijke Philips N.V., Redcare Pharmacy NV and Koninklijke Ahold Delhaize N.V..